KMT2D-mediated H3K4me1 recruits YBX1 to facilitate triple-negative breast cancer progression through epigenetic activation of c-Myc
Bing Yao , Mengying Xing , Xiangwei Zeng , Ming Zhang , Que Zheng , Zhi Wang , Bo Peng , Shuang Qu , Lingyun Li , Yucui Jin , Haitao Li , Hongyan Yuan , Quan Zhao , Changyan Ma
Clinical and Translational Medicine ›› 2024, Vol. 14 ›› Issue (7) : e1753
KMT2D-mediated H3K4me1 recruits YBX1 to facilitate triple-negative breast cancer progression through epigenetic activation of c-Myc
• YBX1 is a KMT2D-mediated H3K4me1-binding effector protein and mutation of YBX1 (E121A) disrupts its binding to H3K4me1. • KMT2D and YBX1 cooperatively promote TNBC proliferation and metastasis by activating c-Myc and SENP1 expression in vitro and in vivo. • YBX1 is colocalized with H3K4me1 in the c-Myc and SENP1 promoter regions in TNBC cells and increased YBX1 expression predicts a poor prognosis in breast cancer patients.
histone H3 lysine 4 mono-methylation (H3K4me1) / lysine methyltransferase 2D (KMT2D) / triple-negative breast cancer (TNBC) / Y-box-binding protein 1 (YBX1)
2024 The Author(s). Clinical and Translational Medicine published by John Wiley & Sons Australia, Ltd on behalf of Shanghai Institute of Clinical Bioinformatics.
/
| 〈 |
|
〉 |
PDF
